secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivakor, Inc. (VIVK)
CIK:        0001450704
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001829126-23-008003
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vivakor director resignation triggers Nasdaq independence non-compliance; cure period to June 2024
--------------------------------------------------------------------------------

- David Natan resigned from Board and all committee positions effective December 6, 2023.
- Board now lacks a majority of independent directors; Audit Committee has only two independent members.
- Nasdaq granted cure period until June 3, 2024 to regain compliance with Listing Rules 5605(b)(1) and 5605(c)(2)(A).
- No immediate effect on listing of common stock on Nasdaq Capital Market.
- Resignation was not due to any dispute with the Company or Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1450704/000182912623008003/0001829126-23-008003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1450704/000182912623008003/vivakor_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-23-008003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer